United Therapeutics (UTHR) Tops Q4 EPS Views
Tweet
Share
E-mailGet Alerts UTHR Hot Sheet
Price: $552.48 --0%
EPS Growth %: +11.9%
Financial Fact:
Operating income: 238.6M
Today's EPS Names:
CCEL, FEIM, PLG, More
EPS Growth %: +11.9%
Financial Fact:
Operating income: 238.6M
Today's EPS Names:
CCEL, FEIM, PLG, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q4 adjusted EPS of $3.21, $1.18 better than the analyst estimate of $2.03. Revenue for the quarter came in at $346.4 million versus the consensus estimate of $336.22 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Delta Air Lines stock climbs on earnings beat and strong guidance
- Cohu (COHU) PT Raised to $70 at Stifel on Expectation of 'More Buoyant Multiple'
- Morgan Stanley downgrades Chinese luxury auto dealers on weak demand
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
